Skip to content

Shozo Fujita

Shozo was awarded his PhD in biochemistry and neurochemistry from Niigata University. Following five additional years at the university performing post-doctoral research, he joined Fujitsu Laboratories Ltd (FLL) as…

Angela Hildreth

Angela is experienced strategically, financially and operationally in developing and commercialising pharmaceutical and consumer healthcare products.  Angela has been FD/COO of Futura Medical Plc (listed on AIM) since 2018…

Prof Rick Body

Rick is a Professor of Emergency Medicine at the University of Manchester, an Honorary Consultant in Emergency Medicine and the Group Director of Research & Innovation at Manchester University…

Dr John Richards

John read Chemistry at St John’s College Oxford prior to completing a DPhil in Peptide Chemistry also at Oxford. Following his doctorate, John carried out post-doctoral research at the…

Dr Ian Gilham

Ian is an experienced CEO and Chairman of life sciences companies.  He is currently Chairman of Genedrive plc (listed on AIM) and Cytox Limited.  From 2014-2021 he was Chairman…

Alastair Fleming

Alastair has held senior executive positions in the life science industry. He has a broad business knowledge over a career spanning 39 years, within several different sectors, including Medical…

Prof Paul Townsend

Paul is the Executive Dean of the Faculty of Health and Medical Sciences and Pro Vice-Chancellor at the University of Surrey. He is also a group leader and Full…

Jenny Cutler

Jenny is a Chartered Accountant (FCA) with over 20 years of finance leadership experience and has worked at AIM and Main Listed business. Most recently, Jenny was Chief Financial…

Dr David Bunka

David holds a Ph.D. in Molecular Biology and has spent nearly 20 years developing nucleic acid aptamers against a wide variety of targets including small molecules (antibiotics, food contaminants,…

Dr Arron Tolley

Arron holds a Ph.D. in Molecular Biology and Biophysics and a B.Sc. in Molecular Medicine from the University of Leeds. Arron has several years’ experience raising aptamers against complex…